Who owns Genenta Science S.p.A.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of GNTA from SEC Form 13F filings across 9 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 9 institutions disclosed 720,676 shares of Genenta Science S.p.A. worth $1.3M — about 3.1% of shares outstanding; the largest disclosed holder is Eurizon Capital SGR S.p.A.. Source: SEC Form 13F filings, parsed by EvidInvest.
9
13F holders
$1.3M
value, 2026 filers
3.1%
of shares outstanding (720,676 sh)
2
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of GNTA's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Eurizon Capital SGR S.p.A. | 360,000 | $662,400 | 0.0% | 1.5% | 0.0% |
| 2 | Allianz SE | 234,050 | $430,652 | 0.0% | 1% | 0.0% |
| 3 | SmartHarvest Portfolios, LLC | 43,856 | $80,695 | 0.0% | 0.2% | -67.4% |
| 4 | Virtu Financial LLCNEW | 36,913 | $68,000 | 0.0% | 0.2% | new |
| 5 | Simplicity Wealth,LLC | 18,590 | $34,206 | 0.0% | 0.1% | +52.2% |
| 6 | Ground Swell Capital, LLCNEW | 14,374 | $26,448 | 0.0% | 0.1% | new |
| 7 | GAMMA Investing LLC | 9,863 | $18,148 | 0.0% | 0% | -31.0% |
| 8 | UBS Group AG | 3,027 | $5,570 | 0.0% | 0% | -2.6% |
| 9 | Farther Finance Advisors, LLC | 3 | $6 | 0.0% | 0% | 0.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.